申请人:Bearss J. David
公开号:US20060264439A1
公开(公告)日:2006-11-23
Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure:
including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein ring moiety A, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
and X are as defined herein. Also disclosed are compositions comprising such compounds and methods of using same.
本发明揭示了具有在治疗蛋白激酶介导的疾病和病况(如癌症)中的用途的蛋白激酶抑制剂。本发明的化合物具有以下结构:包括立体异构体、前药和其药学上可接受的盐,其中环基团A、R1、R2、R3、R4、R5、R6、R7、R8和X的定义如上所述。还揭示了包含这些化合物的组合物和使用它们的方法。